Clinical Trials Browser

Recurrence × tagraxofusp × Clear all

NCT04342962 2025-01-30

Tagraxofusp in Patients With CD123+ or With BPDCN-IPh-like Acute Myeloid Leukemia

Phase 2 Terminated

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT02661022 2024-04-17

SL-401 in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma

Phase 1/2 Terminated

9 enrolled 13 charts

Multiple Myeloma, Recurrence